10,11-Dihydrocarbamazepine structure
|
Common Name | 10,11-Dihydrocarbamazepine | ||
---|---|---|---|---|
CAS Number | 3564-73-6 | Molecular Weight | 238.28 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 394.5±52.0 °C at 760 mmHg | |
Molecular Formula | C15H14N2O | Melting Point | 205-210ºC | |
MSDS | Chinese USA | Flash Point | 192.4±30.7 °C | |
Symbol |
GHS07, GHS08 |
Signal Word | Danger |
Use of 10,11-Dihydrocarbamazepine10,11-Dihydrocarbamazepine is the active metabolite of Oxcarbazepine. 10,11-Dihydrocarbamazepine also is an intermediate. Oxcarbazepine is rapidly and almost completely converted to 10,11-Dihydrocarbamazepine with probable Anticonvulsant efficacy[1]. |
Name | 5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide |
---|---|
Synonym | More Synonyms |
Description | 10,11-Dihydrocarbamazepine is the active metabolite of Oxcarbazepine. 10,11-Dihydrocarbamazepine also is an intermediate. Oxcarbazepine is rapidly and almost completely converted to 10,11-Dihydrocarbamazepine with probable Anticonvulsant efficacy[1]. |
---|---|
Related Catalog | |
In Vitro | Oxcarbazepine is metabolized in the liver to its active metabolite, 10,11-Dihydrocarbamazepine. Oxcarbazepine is an antiepileptic drug (AED) used to treat partial seizures as a monotherapy or adjunctive therapy[1]. 10,11-Dihydrocarbamazepine may be used as a reference standard for the determination of 10,11-dihydrocarbamazepine in pharmaceutical formulations by liquid chromatography (LC)[1]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 394.5±52.0 °C at 760 mmHg |
Melting Point | 205-210ºC |
Molecular Formula | C15H14N2O |
Molecular Weight | 238.28 |
Flash Point | 192.4±30.7 °C |
Exact Mass | 238.110611 |
PSA | 46.33000 |
LogP | 2.60 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.645 |
Storage condition | Refrigerator |
Water Solubility | dichloromethane: soluble2.5%, clear, colorless | Soluble in dichloromethane. Insoluble in water. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H317-H334 |
Precautionary Statements | P261-P280-P342 + P311 |
Hazard Codes | Xn |
Risk Phrases | 22-42/43 |
Safety Phrases | S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | HN8300000 |
HS Code | 2933990090 |
~84% 10,11-Dihydroca... CAS#:3564-73-6 |
Literature: Shamshin, V. P.; Voronin, V. G.; Borisov, M. M.; Mufazalova, T. P. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 6 p. 443 - 448 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 6 p. 711 - 716 |
~85% 10,11-Dihydroca... CAS#:3564-73-6 |
Literature: Dunnbier; Jugelt Pharmazie, 1991 , vol. 46, # 7 p. 512 - 517 |
~% 10,11-Dihydroca... CAS#:3564-73-6 |
Literature: Pharmaceutical Chemistry Journal, , vol. 21, # 6 p. 443 - 448 Khimiko-Farmatsevticheskii Zhurnal, , vol. 21, # 6 p. 711 - 716 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Structure-activity relationship and site of binding of polyamine derivatives at the nicotinic acetylcholine receptor.
Eur. J. Biochem. 267(1) , 110-20, (2000) Several wasp venoms contain philanthotoxins (PhTXs), natural polyamine amides, which act as noncompetitive inhibitors (NCIs) on the nicotinic acetylcholine receptor (nAChR). Effects of varying the str... |
|
Liquid chromatographic methods for assay of carbamazepine, 10,11-dihydrocarbamazepine, and related compounds in carbamazepine drug substance and tablets.
J. Assoc. Off. Anal. Chem. 70(5) , 836-40, (1987) Liquid chromatographic (LC) methods have been developed for the determination of carbamazepine, the impurity 10,11-dihydrocarbamazepine, and related compounds in carbamazepine drug substance and table... |
|
An orthorhombic polymorph of 10,11-dihydrocarbamazepine.
Acta Crystallogr. C 62(Pt 5) , o240-2, (2006) The title compound (systematic name: 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide), C15H14N2O, is shown to crystallize as an orthorhombic polymorph to complement the known monoclinic form. The mo... |
10,11-dihydro-5-carboxamido-5H-dibenz<b,f>azepine |
10,11-Dihydro-5-carbamoyl-5H-dibenz<b,f>azepin |
10,11-Dihydro-5-carbamoyl-5H-dibenz<b,f>azepine |
GP 26-301 |
10,11-DIHYDROCARBAMAZEPINE |
EINECS 222-649-0 |
10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide |
10,11-Dihydrocarbamazepine,10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide |
MFCD00005072 |
10,11-Dihydro-5H-dibenz(b,f)azepine-5-carboxamide |
10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide |
5H-DIBENZ(b,f)AZEPINE-5-CARBOXAMIDE,10,11-DIHYDRO |
5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro- |